What does Ensysce Biosciences, Inc. (ENSC) do?

Ensysce Biosciences, Inc. (ENSC) is a publicly traded company in the Healthcare sector.

What sector does ENSC operate in?

Ensysce Biosciences, Inc. operates in the Healthcare, specifically within the Pharmaceuticals industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find ENSC earnings analysis?

AlphaOS publishes an earnings intelligence page for Ensysce Biosciences, Inc. (ENSC) covering results, guidance context, and AI-assisted analysis. See /stocks/ENSC/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 70%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ENSC

Ensysce Biosciences, Inc.

Healthcare · Pharmaceuticals

$0.40Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Ensysce Biosciences, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -27% YoY in Q1 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -27% YoY in Q1 FY2026

Pipeline evidence · 4d ago

ENSC's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ENSC.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2026

Full ENSC earnings analysis

Reported figures for Ensysce Biosciences, Inc. — research only, not investment advice.

Revenue YoY: -99.9%

Latest Intelligence

Updated September 28, 2026

What happened recently for Ensysce Biosciences, Inc. (ENSC) — events, not interpretation.

Event: Reported Q1 2026 revenue -100% YoY.
Also: Last session September 28, 2026 at $0.4.
Source: Q1 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Ensysce Biosciences, Inc. (ENSC)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for Ensysce Biosciences, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceuticals
Market cap:: $7.80M
Revenue:: $1.88M

ENSC earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Ensysce Biosciences, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Themes

Aging Demographics

Aging Demographics beneficiaries

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.